Ticker Details
Organogenesis Holdings Inc.
IPO Date:	January 2, 2017
Sector:	Healthcare
Industry:	Drug Manufacturers - Specialty and Generic
Market Cap:	$294.59M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.29 | 3.57%
Avg Daily Range (30 D):	$0.09 | 3.07%
Avg Daily Range (90 D):	$0.10 | 2.64%

Institutional Daily Volume
Avg Daily Volume:	.63M
Avg Daily Volume (30 D):	1.42M
Avg Daily Volume (90 D):	.94M

Trade Size
Avg Trade Size (Sh.):	116
Avg Trade Size (Sh.) (30 D):	142
Avg Trade Size (Sh.) (90 D):	118

Institutional Trades
Total Institutional Trades:	914
Avg Institutional Trade:	$2.32M
Avg Institutional Trade (30 D):	$2.57M
Avg Institutional Trade (90 D):	$2.59M
Avg Institutional Trade Volume:	.37M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.04M
Avg Closing Trade (30 D):	$.55M
Avg Closing Trade (90 D):	$.94M
Avg Closing Volume:	257.68K

News

Apr 6, 2026 @ 11:02 PM Organogenesis Achieves Primary Endpoint in Randomi... Source: Na

Feb 3, 2026 @ 6:59 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Dec 30, 2025 @ 9:38 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Nov 20, 2025 @ 6:00 PM Global Wound Healing Devices Market Poised for Rob... Source: Delveinsight

Oct 17, 2025 @ 6:20 PM Organogenesis Holdings Inc. Investigated for Secur... Source: Business Wire

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$.16	$.28	$.16
Diluted EPS	$.15	$.27	$.15
Revenue	$564.17M	$225.61M	$564.17M
Gross Profit
Net Income / Loss	$37.03M	$43.7M	$37.03M
Operating Income / Loss	$44.69M	$63.29M	$44.69M
Cost of Revenue
Net Cash Flow	$-41.82M	$29.96M	$-41.82M
PE Ratio	15.73